patient access

Mike Page, Alexion Pharmaceuticals invite to SMi’s Orphan Drugs & Rare Diseases

https://pharmaphorum.com/partner-content/mike-page-alexion-pharmaceuticals-invite-to-smis-orphan-drugs-rare-diseases/

Innovative contracting in Europe – a Trojan horse?

https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference

https://pharmaphorum.com/events/smis-9th-annual-orphan-drugs-rare-diseases-conference/

Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference

https://pharmaphorum.com/partner-content/registration-opens-for-smis-9th-annual-orphan-drugs-rare-diseases-conference/

Patient access at risk: should stakeholders take an orchestral approach?

https://pharmaphorum.com/views-analysis-patients/patient-access-at-risk-should-stakeholders-take-an-orchestral-approach/

Close in 10 seconds

Pharmaphorum.com

Search